Circulating glycerate predicts resilience to fructose-induced hepatic steatosis

Excessive intake of dietary fructose increases the risk of metabolic-dysfunction-associated steatotic liver disease (MASLD), cirrhosis, and cancers. However, what host factors determine disease vulnerability is incompletely understood. Here, we leverage genetically divergent mouse strains, mass spectrometry-based metabolomics, and in vivo isotope tracing, identifying circulating glycerate as a biomarker that predicts resilience to fructose-induced hepatic steatosis in both sexes. We found that the surge of circulating glycerate after an oral fructose provision reflects strong small-intestinal fructose catabolism. Such fructose clearance by the small intestine is linked to a weaker induction of hepatic de novo lipogenesis and steatosis upon chronic fructose exposure across strains. These data indicate the potential utility of an oral fructose tolerance test and circulating glycerate measurements to predict an individual's susceptibility to fructose-elicited steatotic liver and provide personalized dietary recommendations.

Authors

Institutions

Publication Details

Journal
Cell Metabolism
Published
2025-04-22
DOI
https://doi.org/10.1016/j.cmet.2025.03.017
Citations
3
Primary Topic
Diet, Metabolism, and Disease
Type
article
Field-Weighted Citation Impact
3.88
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Circulating glycerate predicts resilience to fructose-induced hepatic steatosis

Hosung Bae, Varvara I. Rubtsova, Yasmine H. Alam, Sunhee Jung et al.
3 citations
Cell Metabolism
Diet, Metabolism, and Disease
3.88
article

Circulating glycerate predicts resilience to fructose-induced hepatic steatosis

Hosung Bae, Varvara I. Rubtsova, Yasmine H. Alam, Sunhee Jung, Cholsoon Jang, Daniele Piomelli, Ingrid Cely, Xing Dai, Lauren Hoffner, Graciel Diamante, Joo‐Hwan Kim, Gina Lee, Yeojin Kim, A. Chun-Hui Tsai, Cuauhtemoc B. Ramirez, Johnny Le, Xia Yang, Alexis Anica, Guanglin Zhang, Miranda Lopez, Alina Chao, Won-Suk Song, In Sook Ahn, M. Kelly, Ian Tamburini, Qin Yang, Elena M. Moyer
article en
3 citations

Abstract

Excessive intake of dietary fructose increases the risk of metabolic-dysfunction-associated steatotic liver disease (MASLD), cirrhosis, and cancers. However, what host factors determine disease vulnerability is incompletely understood. Here, we leverage genetically divergent mouse strains, mass spectrometry-based metabolomics, and in vivo isotope tracing, identifying circulating glycerate as a biomarker that predicts resilience to fructose-induced hepatic steatosis in both sexes. We found that the surge of circulating glycerate after an oral fructose provision reflects strong small-intestinal fructose catabolism. Such fructose clearance by the small intestine is linked to a weaker induction of hepatic de novo lipogenesis and steatosis upon chronic fructose exposure across strains. These data indicate the potential utility of an oral fructose tolerance test and circulating glycerate measurements to predict an individual's susceptibility to fructose-elicited steatotic liver and provide personalized dietary recommendations.

Cell MetabolismVol. 37(5)
University of California, Los Angeles (US), University of California, Irvine (US), Irvine University (US)
Climate action
Openalex Percentile: Top 7%
Diet, Metabolism, and Disease
3.88
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.